✦ LIBER ✦

Mutations of hepatitis C virus 1b NS5A 2209–2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients

✍ Scribed by Hafida Khorsi; Sandrine Castelain; Ann Wyseur; Jacques Izopet; Valérie Canva; Annelies Rombout; Dominique Capron; Jean-Pierre Capron; Françoise Lunel; Lieven Stuyver; Gilles Duverlie

Book ID: 118567697
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 730 KB
Volume: 27
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(97)80282-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of genotypes and amino acid res

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy

✍ M Kurosaki; N Enomoto; T Murakami; I Sakuma; Y Asahina; C Yamamoto; T Ikeda; S T 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

of patients with a high likelihood of response to IFN-b. In chronic hepatitis C virus (HCV) infection, geno-(HEPATOLOGY 1997;25:750-753.) types other than genotype 1b of HCV (HCV-1b) and low serum HCV-RNA levels are known to be associated with favorable outcome of interferon alfa (IFN-a) therapy. In

Mutations in the NS5A region do not pred

Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus

✍ Chung, Raymond T.; Monto, Alexander; Dienstag, Jules L.; Kaplan, Lee M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

A striking association has been demonstrated recently between mutations in amino acid residues 2209-2248 of the nonstructural protein 5a (NS5a) region of hepatitis C virus (HCV) and sustained responses to interferon in Japanese patients infected with genotype 1b. Therefore, analysis of this sequence

Mutations in the interferon sensitivity-

Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

✍ Y.-H. YEN; C.-H. HUNG; T.-H. HU; C.-H. CHEN; C.-M. WU; J.-H. WANG; S.-N. LU; C.- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Mutations in the NS5A and E2-PePHD regio

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin

✍ Sheng-Shun Yang; Ming-Yang Lai; Ding-Shinn Chen; Gran-Hum Chen; Jia-Horng Kao 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Su1067 Drug Resistance Mutations in the

Su1067 Drug Resistance Mutations in the Ns3 and NS5A Regions in Patients With Hepatitis C Virus Genotype 1b and Response to Telaprevir Plus Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy

✍ Hayashi, Kazuhiko; Ishigami, Masatoshi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Taka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB